Trade Personalis, Inc. - PSNL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.36 |
| Open | 1.29 |
| 1-Year Change | -47.13% |
| Day's Range | 1.27 - 1.31 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 23, 2024 | 1.36 | 0.13 | 10.57% | 1.23 | 1.39 | 1.22 |
| Apr 22, 2024 | 1.24 | -0.01 | -0.80% | 1.25 | 1.27 | 1.21 |
| Apr 19, 2024 | 1.28 | 0.11 | 9.40% | 1.17 | 1.28 | 1.17 |
| Apr 18, 2024 | 1.19 | 0.02 | 1.71% | 1.17 | 1.24 | 1.15 |
| Apr 17, 2024 | 1.18 | -0.07 | -5.60% | 1.25 | 1.25 | 1.15 |
| Apr 16, 2024 | 1.22 | -0.01 | -0.81% | 1.23 | 1.25 | 1.19 |
| Apr 15, 2024 | 1.24 | -0.05 | -3.88% | 1.29 | 1.29 | 1.22 |
| Apr 12, 2024 | 1.25 | -0.08 | -6.02% | 1.33 | 1.34 | 1.24 |
| Apr 11, 2024 | 1.34 | 0.00 | 0.00% | 1.34 | 1.37 | 1.34 |
| Apr 10, 2024 | 1.35 | -0.01 | -0.74% | 1.36 | 1.40 | 1.33 |
| Apr 9, 2024 | 1.43 | 0.07 | 5.15% | 1.36 | 1.44 | 1.36 |
| Apr 8, 2024 | 1.39 | 0.02 | 1.46% | 1.37 | 1.39 | 1.35 |
| Apr 5, 2024 | 1.36 | 0.00 | 0.00% | 1.36 | 1.37 | 1.34 |
| Apr 4, 2024 | 1.36 | -0.01 | -0.73% | 1.37 | 1.44 | 1.36 |
| Apr 3, 2024 | 1.33 | -0.02 | -1.48% | 1.35 | 1.36 | 1.31 |
| Apr 2, 2024 | 1.35 | -0.05 | -3.57% | 1.40 | 1.40 | 1.34 |
| Apr 1, 2024 | 1.41 | -0.07 | -4.73% | 1.48 | 1.50 | 1.39 |
| Mar 28, 2024 | 1.48 | 0.03 | 2.07% | 1.45 | 1.51 | 1.44 |
| Mar 27, 2024 | 1.43 | 0.02 | 1.42% | 1.41 | 1.44 | 1.38 |
| Mar 26, 2024 | 1.41 | -0.07 | -4.73% | 1.48 | 1.50 | 1.39 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Personalis, Inc. Company profile
About Personalis Inc
Personalis, Inc. is a cancer genomics company, which enables precision cancer therapies and diagnostics. The Company is focused on the development of therapies by providing molecular data about each patient's cancer and immune response. It provides sequencing and data analysis services to support the development of cancer therapies. Its NeXT Platform, which provides its biopharmaceutical customers with information on over 20,000 human genes, together with the immune system, in contrast to many cancer panels that cover over 50 to 500 genes. Its NeXT Platform is designed to provide analysis of both a tumor and its immune microenvironment from a single limited tissue sample. Its platform covers the deoxyribonucleic acid sequence of all of the approximately 20,000 human genes. It also reports on transcriptome of a tumor, which encompasses ribonucleic acid expression across human genes, allowing it to determine which of the genomic mutations might actually be driving tumor progression.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Personalis Inc revenues increased 9% to $85.5M. Net loss increased 58% to $65.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development increase of 69% to $45.2M (expense), Selling, general, and administrative increase of 38% to $38.8M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
1330 O'brien Drive
MENLO PARK
CALIFORNIA 94025
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com